Co-Authors
This is a "connection" page, showing publications co-authored by Heidi Fischer and Jacek Skarbinski.
Connection Strength
1.049
-
Prior Screening for Latent Tuberculosis Among Patients Diagnosed With Tuberculosis Disease: Missed Opportunities? Open Forum Infect Dis. 2023 Nov; 10(11):ofad545.
Score: 0.231
-
Real-World Evidence to Supplement Randomized Clinical Trials: Tocilizumab for Severe COVID-19 Pneumonia vs. a Cohort Receiving Standard of Care. Clin Pharmacol Ther. 2023 Nov; 114(5):1073-1081.
Score: 0.229
-
Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19. BMJ Open. 2022 10 31; 12(10):e060358.
Score: 0.216
-
Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems. PLoS One. 2022; 17(8):e0273363.
Score: 0.213
-
Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system. Clin Infect Dis. 2024 Jan 11.
Score: 0.059
-
Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System. JMIR Public Health Surveill. 2022 12 30; 8(12):e41529.
Score: 0.055
-
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med. 2020 11 17; 173(10):773-781.
Score: 0.046